The objectives of this research were to evaluate the accuracy and robustness of genomic methods used for genomic selection under various underlying genetic models and marker densities and for these various models to compare the accuracy of genomic selection when the validation individuals were one generation, several generations, or one sub-population removed from the prediction animals.
The use of genomic microarrays in combination with methods such as chromatin immunoprecipitation (ChIP-chip) [16] [18], are powerful high-throughput approaches which allow events associated with the transcription of genes and the activity of their regulatory sequences to be elucidated in vivo.
So far, many members of MAPK cascades have been identified using functional genomic methods.
The results of profiling miRNA using genomic methods have proven to be very platform dependent.
The increasing clinical use of genomic profiling demands identification of more effective methods to segregate patients into prognostic and treatment groups.
In addition, sites are developing novel patient and provider educational models; testing CDS strategies to support clinical use of genomic data; utilizing novel dissemination and sustainability methods; and collecting data on factors influencing adoption of genomic medicine.
Much of this complexity is difficult to detect using standard population genomic methods, and limitations of current methods need to be considered when designing the screening approach, and when basing management decisions on genomic data (e.g. by screening coding and noncoding parts of the genome and not routinely biasing management decisions to large-effect loci).
Currently we are witnessing an era in which molecular diagnostics utilising nucleic acids are reliable enough for use in patient care and for broad clinical application; however, despite the tremendous number of potential biomarkers found using high-throughput genomic methods, only a few have been vigorously validated and are used for clinical diagnosis.
In the present work however, we perform whole genome comparisons of 32 Brucella genomes (Table 1) using a variety of different genomic methods to obtain deeper insight into the obscure evolution of genus Brucella.
The second data set, described in detail by Cleveland et al. (2012), is a real pig (Sus scrofa) data, provided by the Genetics Society of America to be used for benchmarking of genomic selection methods.
